Mantecorp Industria Quimica e Farmaceutica Ltd.

Quick facts

Marketed products

• ibuprofen, dipyrone, acetaminophen

Phase 3 pipeline

• Dexchlorpheniramine 1% gel · Dermatology / Allergy
  Dexchlorpheniramine is a selective H1-receptor antagonist that blocks histamine-mediated allergic and inflammatory responses in topical form.
• Dexchlorpheniramine 1% lotion · Dermatology / Allergy
  Dexchlorpheniramine is a first-generation H1-receptor antagonist that blocks histamine binding to reduce allergic and inflammatory responses in the skin.
• Dexchlorpheniramine, pseudoephedrine, guaifenesin · Respiratory/Allergy
  This combination drug reduces allergy symptoms via antihistamine action, nasal congestion via sympathomimetic decongestant, and cough via expectorant action.
• Glucosamine sulfate + chondroitin sulfate - CONDROFLEX · Rheumatology/Orthopedics
  Glucosamine sulfate and chondroitin sulfate work together to provide substrate for cartilage synthesis and reduce cartilage degradation in osteoarthritis.
• Glucosamine sulfate + chondroitin sulfate - MANTECORP · Rheumatology / Orthopedics
  Glucosamine sulfate and chondroitin sulfate work together to provide substrates for cartilage matrix synthesis and reduce cartilage degradation in osteoarthritis.
• Ibuprofen plus caffeine · Pain Management
  Ibuprofen inhibits cyclooxygenase enzymes to reduce prostaglandin synthesis and inflammation, while caffeine enhances analgesic efficacy and reduces drowsiness.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Mantecorp Industria Quimica e Farmaceutica Ltd. portfolio CI brief
• Mantecorp Industria Quimica e Farmaceutica Ltd. pipeline updates RSS